Advertisement

Reproductive rheumatology: the male perspective

  • Timo Tolppa
  • Isabella Plumptre
  • Maria MouyisEmail author
Letter to the Editor

Notes

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Clowse MEB (2018) Introduction. Rheumatology 57(suppl_5):v1.  https://doi.org/10.1093/rheumatology/key272 CrossRefGoogle Scholar
  2. 2.
    Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C (2014) No evidence for an increased risk of adverse pregnancy out come after paternal low-dosemethotrexate: an observational cohort study. Rheumatology (Oxford) 53(4):757–763CrossRefGoogle Scholar
  3. 3.
    Mouyis M, Flint JD, Giles IP (2018) Safety of anti-rheumatic drugs in men trying to conceive: a systematic review and analysis of published evidence. Semin Arthritis Rheum.  https://doi.org/10.1016/j.semarthrit.2018.07.011.
  4. 4.
    Micu MC, Ostensen M, Villiger PM, Micu R, Ionescu R (2018) Paternal exposure to antirheumatic drugs-what physicians should know: review of the literature. Semin Arthritis Rheum 48(2):343–355CrossRefGoogle Scholar
  5. 5.
    Sarkar O, Bahrainwala J, Chandrasekaran S, Kothari S, Mathur PP, Agarwal A (2011) Impact of inflammation on male fertility. Frontiers in bioscience (Elite edition) 3:89–95Google Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Rheumatology DepartmentNorthwick Park HopsitalLondonUK

Personalised recommendations